Applying the same cut‐off value (1.12 ng/ml) to all VCA‐IgA‐negative individuals yielded a sensitivity of 90.2% and a specificity of 85.9% for NPC diagnosis (Fig 1J). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.